{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:43:57Z","timestamp":1792118637139,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.mayocp.2013.09.016","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T06:30:40Z","timestamp":1388730640000},"page":"95-106","source":"Crossref","is-referenced-by-count":356,"title":["Drug-Induced Liver Injury"],"prefix":"10.1016","volume":"89","author":[{"given":"Michael D.","family":"Leise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Poterucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant A.","family":"Talwalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2013.09.016_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mayocp.2013.09.016_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mayocp.2013.09.016_bib3","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.mayocp.2013.09.016_bib4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ajg.2012.138","article-title":"A\u00a0prospective nationwide study of drug-induced liver injury in Korea","volume":"107","author":"Suk","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.mayocp.2013.09.016_bib5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bjornsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.mayocp.2013.09.016_bib6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/MEG.0b013e32835f6889","article-title":"Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21 789 patients","volume":"25","author":"Zhou","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.mayocp.2013.09.016_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Int Med"},{"issue":"6","key":"10.1016\/j.mayocp.2013.09.016_bib8","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter, prospective study","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.mayocp.2013.09.016_bib9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2013I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.mayocp.2013.09.016_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mayocp.2013.09.016_bib11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.mayocp.2013.09.016_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2011.02.019","article-title":"Clinical and histopathologic features of fluoroquinolone-induced liver injury","volume":"9","author":"Orman","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.mayocp.2013.09.016_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cgh.2012.12.025","article-title":"Liver injury from tumor necrosis factor-alpha antagonists: analysis of thirty-four cases","volume":"11","author":"Ghabril","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mayocp.2013.09.016_bib14","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mayocp.2013.09.016_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cld.2007.06.003","article-title":"Causality assessment of drug-induced hepatotoxicity: promises and pitfalls","volume":"11","author":"Shapiro","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2013.09.016_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200730040-00001","article-title":"Drug-induced liver injury","volume":"30","author":"Abboud","year":"2007","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.mayocp.2013.09.016_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00004836-199404000-00013","article-title":"Drug disposition and hepatotoxicity in the elderly","volume":"18","author":"Schenker","year":"1994","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"8","key":"10.1016\/j.mayocp.2013.09.016_bib18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic","volume":"24","author":"De Valle","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.mayocp.2013.09.016_bib19","first-page":"CR292","article-title":"Drug-induced liver damage \u2013 a three-year study of patients from one gastroenterological department","volume":"8","author":"Hartleb","year":"2002","journal-title":"Med Sci Monit"},{"issue":"6","key":"10.1016\/j.mayocp.2013.09.016_bib20","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.22895","article-title":"Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex","volume":"49","author":"Lucena","year":"2009","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.mayocp.2013.09.016_bib21","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.mayocp.2013.09.016_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-104-3-399","article-title":"Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure","volume":"104","author":"Seeff","year":"1986","journal-title":"Ann Int Med"},{"issue":"3","key":"10.1016\/j.mayocp.2013.09.016_bib23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.1840220312","article-title":"Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure","volume":"22","author":"Zimmerman","year":"1995","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.mayocp.2013.09.016_bib24","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.1994.03520230055038","article-title":"Association of acetaminophen hepatotoxicity with fasting and ethanol use","volume":"272","author":"Whitcomb","year":"1994","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2013.09.016_bib25","first-page":"511","article-title":"Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics","volume":"85","author":"Nyfors","year":"1977","journal-title":"Acta Pathol Microbiol Scand A"},{"issue":"1","key":"10.1016\/j.mayocp.2013.09.016_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hep.510310129","article-title":"Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection","volume":"31","author":"Wong","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mayocp.2013.09.016_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2013.09.016_bib28","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jhep.2012.12.018","article-title":"Drug-induced liver injury in obesity","volume":"58","author":"Fromenty","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.mayocp.2013.09.016_bib29","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.22272","article-title":"Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals","volume":"47","author":"Lammert","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mayocp.2013.09.016_bib30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.26208","article-title":"High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury","volume":"58","author":"Chen","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mayocp.2013.09.016_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hep.23317","article-title":"Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events","volume":"51","author":"Lammert","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mayocp.2013.09.016_bib32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jhep.2010.05.033","article-title":"Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury","volume":"53","author":"Donaldson","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.mayocp.2013.09.016_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.26077","article-title":"Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury","volume":"57","author":"Monshi","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mayocp.2013.09.016_bib34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.gastro.2006.11.023","article-title":"Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes","volume":"132","author":"Daly","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.mayocp.2013.09.016_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/jhep.2002.32102","article-title":"Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis","volume":"35","author":"Huang","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mayocp.2013.09.016_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/clpt.1991.3","article-title":"Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions","volume":"49","author":"Rieder","year":"1991","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2013.09.016_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","article-title":"Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury","volume":"17","author":"Lang","year":"2007","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"10.1016\/j.mayocp.2013.09.016_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/599319","article-title":"Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"200","author":"Kuniholm","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2013.09.016_bib39","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","article-title":"Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury","volume":"141","author":"Davern","year":"2011","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.mayocp.2013.09.016_bib40","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2036.2007.03504.x","article-title":"The role of hepatitis E virus testing in drug-induced liver injury","volume":"26","author":"Dalton","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.mayocp.2013.09.016_bib41","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.24538","article-title":"Circulating microRNAs as potential markers of human drug-induced liver injury","volume":"54","author":"Starkey Lewis","year":"2011","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.mayocp.2013.09.016_bib42","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2013.09.016_bib43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2036.2011.04982.x","article-title":"Serum proteomic profiling in patients with drug-induced liver injury","volume":"35","author":"Bell","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.mayocp.2013.09.016_bib44","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.24060","article-title":"Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure","volume":"53","author":"Khandelwal","year":"2011","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.mayocp.2013.09.016_bib45","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts","volume":"163","author":"Fick","year":"2003","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.mayocp.2013.09.016_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2710.2007.00793.x","article-title":"Inappropriate prescribing in the elderly","volume":"32","author":"Gallagher","year":"2007","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"5","key":"10.1016\/j.mayocp.2013.09.016_bib47","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ajg.2010.102","article-title":"The myth of statin-induced hepatotoxicity","volume":"105","author":"Bader","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"8A","key":"10.1016\/j.mayocp.2013.09.016_bib48","doi-asserted-by":"crossref","first-page":"77C","DOI":"10.1016\/j.amjcard.2005.12.014","article-title":"An assessment of statin safety by hepatologists","volume":"97","author":"Cohen","year":"2006","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2013.09.016_bib49","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2011.07.023","article-title":"Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing","volume":"56","author":"Bjornsson","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.mayocp.2013.09.016_bib50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40264-013-0048-4","article-title":"Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives","volume":"36","author":"Shah","year":"2013","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.mayocp.2013.09.016_bib51","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MCG.0b013e318276bf00","article-title":"Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience","volume":"47","author":"Ghabril","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.mayocp.2013.09.016_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12109","article-title":"Review article: herbal and dietary supplement hepatotoxicity","volume":"37","author":"Bunchorntavakul","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.mayocp.2013.09.016_bib53","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.56.10.1405","article-title":"Effect of L-carnitine treatment for valproate-induced hepatotoxicity","volume":"56","author":"Bohan","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mayocp.2013.09.016_bib54","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","article-title":"Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure","volume":"137","author":"Lee","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mayocp.2013.09.016_bib55","series-title":"Drug-Induced Liver Disease","author":"Zimmerman","year":"1978"},{"issue":"2","key":"10.1016\/j.mayocp.2013.09.016_bib56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bjornsson","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mayocp.2013.09.016_bib57","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1542\/peds.55.6.871","article-title":"Acetaminophen poisoning and toxicity","volume":"55","author":"Rumack","year":"1975","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.mayocp.2013.09.016_bib58","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1053\/j.gastro.2010.06.007","article-title":"Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations","volume":"139","author":"Strnad","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mayocp.2013.09.016_bib59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.25656","article-title":"Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: early discrimination between survival and death","volume":"56","author":"Remien","year":"2012","journal-title":"Hepatology"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619613009312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619613009312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T07:53:49Z","timestamp":1647849229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619613009312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0025619613009312"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2013.09.016","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}